Seizure disorders Archives - MPR Wed, 17 Apr 2024 15:54:55 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.empr.com/wp-content/uploads/sites/7/2023/03/cropped-empr-32x32.jpg Seizure disorders Archives - MPR 32 32 ACTHAR GEL https://www.empr.com/drug/acthar-gel/ Mon, 06 Feb 2023 21:00:52 +0000 https://www.empr.com/drug/h-p-acthar-gel/ Additional Administration Options Approved for Seizure Medication Xcopri https://www.empr.com/home/news/additional-administration-options-approved-for-seizure-medication-xcopri/ Thu, 11 Apr 2024 17:15:00 +0000 https://www.empr.com/?p=218609 The Food and Drug Administration (FDA) has approved 2 new administration options for Xcopri® (cenobamate tablets) for the treatment of adults with partial-onset seizures. 

Xcopri tablets can now either be swallowed whole or be crushed. The crushed tablet can be mixed with water and either administered by mouth as an oral suspension or administered via a nasogastric tube. 

The labeling update is supported by data from an open-label, randomized, single-center, 3-period, 6-sequence, balanced crossover study. Findings showed the plasma Cmax and AUC for Xcopri crushed tablets mixed in water, administered either orally or through a nasogastric tube, were similar to whole tablets.

“The approval addresses the needs of patients living with epilepsy who are currently taking, or who may benefit from starting Xcopri, but are unable to swallow the tablets whole,” said Louis Ferrari, BS, RPh, MBA, vice president, Medical Affairs at SK Life Science. “In some patients, crushing tablets offers an additional option for dosing and administration by nasogastric tube. This label update addresses an unmet need for this patient population and offers administration alternatives to the health care providers managing their care.”

Xcopri is available as 12.5mg-, 25mg-, 50mg-, 100mg-, 150mg-, and 200mg-strength tablets.

]]>
Antiepileptic Drug Indications https://www.empr.com/charts/antiepileptic-drug-indications/ Sat, 15 Sep 2018 18:39:42 +0000 https://www.empr.com/uncategorized/antiepileptic-drug-indications/ #articleColumn table.wkm ul li{padding: 0 0 10px 1em;}#articleColumn table.wkm p{ margin-bottom: 0;line-height: 120%;}.wkm-div {overflow: auto; }.wkm-SeeOnPhone { display: none; }thead.wkm {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bold; font-size: 11px; font-style: normal; background-color: #D3DFE5; margin-top: 0; margin-bottom: 0; vertical-align: bottom; }tbody.wkm {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-size: 11px; font-weight: normal; font-style: normal; line-height: 120% ; text-align: left; background-color: #F4F7F8; margin-top: 0; margin-bottom: 0; vertical-align: top; }tfoot.wkm {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-size: 9px; font-weight: normal; font-style: normal; line-height: 120% ; text-align: left; background-color: #F4F7F8; margin-top: 0; margin-bottom: 0; vertical-align: top; }p.wkm-hang { margin-top: 0; margin-bottom: 0; margin-left: 1em; text-indent: -1em; }th.wkm-intro {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: normal; font-size: 11px; font-style: normal; vertical-align: bottom; text-align: left; line-height: 120% ; background-color: white; border: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; margin-top: 0; margin-bottom: 0; }.wkm-spannerlvl1left {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bolder; font-size: 12px; line-height: 120% ; text-transform: uppercase ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #7091A1; color: white; text-align: left; }.wkm-spannerlvl2left {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bolder; font-size: 12px; line-height: 120% ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #C0D1DA; color: black; text-align: left; }.wkm-spannerlvl3left {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bolder; font-size: 11px; line-height: 120% ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #D3DFE5; color: black; text-align: left; }@media only screen and (max-width: 480px) { .wkm-SeeOnPhone { display: inline; } thead.wkm {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bold; font-size: 12px; font-style: normal; background-color: #D3DFE5; margin-top: 0; margin-bottom: 0; vertical-align: bottom; } tbody.wkm {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-size: 11px; font-weight: normal; font-style: normal; line-height: 120% ; text-align: left; background-color: #F4F7F8; margin-top: 0; margin-bottom: 0; vertical-align: top; } tfoot.wkm {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-size: 10px; font-weight: normal; font-style: normal; line-height: 120% ; text-align: left; background-color: #F4F7F8; margin-top: 0; margin-bottom: 0; vertical-align: top; } p.wkm-hang { margin-top: 0; margin-bottom: 0; margin-left: .5em; text-indent: -.5em; } th.wkm-intro {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: normal; font-size: 11px; font-style: normal; vertical-align: bottom; text-align: left; line-height: 120% ; background-color: white; border: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; margin-top: 0; margin-bottom: 0; } .wkm-tchead { vertical-align: bottom; line-height: 120% ; text-align: left; border-top: none; border-bottom: none; border-left: none; border-right: none; border-collapse: collapse; padding-top: 1px; padding-bottom: 1px; padding-right: 0px; padding-left: 0px; font-weight: bold; font-size: 8px; font-stretch: ultra-condensed; background-color: #D3DFE5; margin-top: 0; margin-bottom: 0; vertical-align: bottom; } .wkm-spannerlvl1left {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bolder; font-size: 12px; line-height: 120% ; text-transform: uppercase ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #7091A1; color: white; text-align: left; } .wkm-spannerlvl2left {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bolder; font-size: 12px; line-height: 120% ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #C0D1DA; color: black; text-align: left; } .wkm-spannerlvl3left {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bolder; font-size: 9px; line-height: 120% ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #D3DFE5; color: black; text-align: left; } }.wkm-straphead {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-size: 14px; font-weight: bold; color: white; text-align: center; background-color: #557A8C; }table.wkm {border: none; border-collapse: collapse; }th.wkm-inside { vertical-align: bottom; line-height: 120% ; text-align: left; border-top: none; border-bottom: none; border-left: 2px dotted gray; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }th.wkm-tchead { vertical-align: bottom; line-height: 120% ; text-align: left; border-top: none; border-bottom: none; border-left: none; border-right: none; border-collapse: collapse; padding-top: 1px; padding-bottom: 1px; padding-right: 0px; padding-left: 0px; font-weight: bold; font-size: 9.5px; font-stretch: ultra-condensed; background-color: #D3DFE5; margin-top: 0; margin-bottom: 0; vertical-align: bottom; } th.wkm { vertical-align: bottom; line-height: 120% ; text-align: left; border-top: none; border-bottom: none; border-left: none; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-first { border-top: none; border-bottom: none; border-left: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-first { border-top: none; border-bottom: none; border-left: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-inside { border-top: none; border-bottom: none; border-left: 2px dotted gray; border-right: 2px dotted gray; border-collapse: collapse;padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-last { border-top: none; border-bottom: none; border-left: 2px dotted gray; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-first-topdotted { border-top: 2px dotted gray; border-bottom: 1px solid black; border-left: none; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-inside-topdotted { border-top: 2px dotted gray; border-bottom: none; border-left: 2px dotted gray; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-last-topdotted { border-top: 2px dotted gray; border-bottom: none; border-left: 2px dotted gray; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-first-topdashed { border-top: 2px dashed b7b7b7; border-bottom: none; border-left: none; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-inside-topdashed { border-top: 2px dashed #b7b7b7; border-bottom: none; border-left: 2px dotted gray; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-topdashed { border-top: 2px dashed #b7b7b7; border-bottom: none; border-left: 2px dotted gray; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-last-topdashed { border-top: 2px dashed #b7b7b7; border-bottom: none; border-left: 2px dotted gray; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-foot-bot { border-top: none; border-bottom: 4px solid #C0D1DA; border-left: none; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-foot { border-top: none; border-bottom: none; border-left: none; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-list { border-top: none; border-bottom: none; border-left: none; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm { border-top: none; border-bottom: none; border-left: 2px dotted gray; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }p.wkm-sub-hang { margin-top: 0; margin-bottom: 0; margin-left: 3.1em; text-indent: -1em; padding-bottom: 0px; }p.wkm-foot-hang { margin-top: 0!important; margin-bottom: 0!important; margin-left: 1em!important; text-indent: -1em!important; padding-bottom: 0px!important;font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif!important; font-size: 10px!important; font-weight: normal; font-style: normal; line-height: 130%!important; text-align: left;}p.wkm-foot { margin-top: 0!important; margin-bottom: 0!important; padding-bottom: 0px!important; font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif!important; font-size: 10px!important; font-weight: normal; font-style: normal; line-height: 130%!important; text-align: left;}p.wkm-revision { font-size: 9px!important; text-align: right!important; margin-top: 0!important; margin-bottom: 0!important; padding-bottom: 0px!important; }p.wkm-bit-of-space { font-size: 5px!important; line-height: 25% !important; margin-top: 0!important; margin-bottom: 0!important; padding-bottom: 0px!important; }p.wkm { margin-top: 0; margin-bottom: 0; margin-right: 0; margin-left: 0; text-indent: 0; padding-bottom: 0px; }.wkm-brand { font-weight: bold;font-size: 11px;}.wkm-bold { font-weight: bold; }.wkm-company { font-style: italic; font-weight: normal; }.wkm-spannernotehead {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bold; font-size: 12px; line-height: 120% ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #7091A1; color: white; text-align: left; }

Antiepileptic Drug Indications

ANTIEPILEPTIC DRUG INDICATIONS
Partial Generalized
Generic Brand Form Simple Complex Absence Myoclonic Tonic-clonic Atonic Mixed Status Epilepticus Lennox-Gastaut Others7
Adrenocorticotropic Hormone (Acth) Analogue
corticotrophin H.P. Acthar Gel gel for IM, SC inj
Alpha-2 Delta Ligand
pregabalin Lyrica CV caps, oral susp 1 1
AMPA GLUTAMATE RECEPTOR ANTAGONIST
perampanel Fycompa CIII tabs, oral susp 1
ANTIEPILEPTICS
brivaracetam Briviact CV tabs, oral soln, IV inj
cenobamate Xcopri CV tabs
divalproex sodium Depakote del-rel tabs 1
Depakote ER ext-rel tabs 1
Depakote Sprinkle del-rel coated particles in caps 1
gabapentin Neurontin caps, tabs, oral soln 1 1
levetiracetam Keppra tabs, oral soln, IV inj 1 1
Keppra XR ext-rel tabs
Spritam tabs for oral susp 1 1
rufinamide Banzel tabs, oral susp 1
stiripentol Diacomit caps, oral susp
valproate sodium IV inj 2 2 1,2
valproic acid caps, syrup 1
vigabatrin Sabril tabs, pwd for oral soln 1,3
BARBITURATE
phenobarbital Sezaby CIV IV inj
primidone Mysoline tabs
BENZODIAZEPINE
clobazam Onfi CIV tabs, oral soln 1
Sympazan CIV oral films 1
clonazepam CIV ODT 3
Klonopin CIV tabs 3
diazepam CIV IM, IV inj 1 1
oral soln 1 1 1 1 1,5 1 1 1
Diastat CIV rectal gel
Diazepam Intensol CIV oral soln 1 1 1 1 1,5 1 1 1
Valium CIV tabs 1 1 1 1 1,5 1 1 1
Valtoco CIV nasal spray
lorazepam Ativan CIV IM, IV inj
midazolam Nayzilam CIV nasal spray
Seizalam CIV IM inj
CANNABINOID
cannabidiol Epidiolex CV oral soln
DIBENZAZEPINE
carbamazepine Carbatrol ext-rel caps
Equetro ext-rel caps
Tegretol tabs, oral susp
Tegretol XR ext-rel tabs
eslicarbazepine Aptiom tabs
oxcarbazepine Oxtellar XR ext-rel tabs
Trileptal tabs, oral susp
GABAA RECEPTOR MODULATOR
ganaxolone Ztalmy CV oral susp
HYDANTOIN
fosphenytoin Cerebyx IV, IM inj 2 2 6
phenytoin IV inj 6
Dilantin ext-rel caps, oral susp
Dilantin Infatabs chew tabs
Phenytek ext-rel caps
PHENYLTRIAZINE
lamotrigine Lamictal tabs, chew tabs, ODT 1,4 1,4 1 1
Lamictal XR  ext-rel tabs 1,4 1,4 1
SODIUM CHANNEL INACTIVATOR
lacosamide Vimpat CV tabs, oral soln, IV inj 1
SUCCINIMIDE
ethosuximide Zarontin caps, syrup
methsuximide Celontin caps 3
SULFAMATE
topiramate coated beads in caps 1
Eprontia oral soln 1
Qudexy XR ext-rel caps 1
Topamax caps, tabs 1
Trokendi XR ext-rel caps 1
SULFONAMIDE
zonisamide Zonegran caps 1 1
SYMPATHOMIMETIC
fenfluramine Fintepla CIV oral soln
NOTES

Key: AED = antiepileptic drug; del-rel = delayed-release; ext-rel = extended-release; ODT = orally-disintegrating tablets

1 Adjunct therapy only.

2 Temporary alternative to oral therapy.

3 Only if refractory to other therapy.

4 Conversion to monotherapy in adults with partial seizures who are on a single AED (see full labeling).

5 Also indicated for tonic seizure.

6 For generalized tonic-clonic status epilepticus.

7 Other indications include infantile spasms, neonatal seizures, Dravet syndrome, recurrent seizures, multiple seizure types, cluster seizures (episodes of increased seizure activity), neurosurgically-induced seizures, seizures due to cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder; see full labeling.

Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact company for full drug labeling.

(Rev. 6/2023)

]]>
APTIOM https://www.empr.com/drug/aptiom/ Thu, 22 Jul 2021 11:32:33 +0000 https://www.empr.com/drug/aptiom/ APTIOMEslicarbazepine acetate 200mg+, 400mg, 600mg+, 800mg+; (+) scored tabs.]]> APTIOM]]> ATIVAN INJECTION https://www.empr.com/drug/ativan-injection/ Fri, 17 Feb 2023 16:02:30 +0000 https://www.empr.com/drug/ativan-injection/ BANZEL https://www.empr.com/drug/banzel/ Thu, 22 Jul 2021 11:06:40 +0000 https://www.empr.com/drug/banzel/ BANZELRufinamide 200mg, 400mg; scored tabs.]]> BANZEL]]> BANZEL ORAL SUSPENSION https://www.empr.com/drug/banzel-oral-suspension/ Thu, 22 Jul 2021 11:17:24 +0000 https://www.empr.com/drug/banzel-oral-suspension/ BANZEL ORAL SUSPENSIONRufinamide 40mg/mL; orange-flavor; lactose-, gluten-, and dye-free.]]> BANZEL ORAL SUSPENSION]]> BRIVIACT https://www.empr.com/drug/briviact/ Thu, 01 Jun 2023 18:31:31 +0000 https://www.empr.com/drug/briviact/ BRIVIACT INJECTION https://www.empr.com/drug/briviact-injection/ Wed, 01 Sep 2021 18:50:21 +0000 https://www.empr.com/drug/briviact-injection/ BRIVIACT ORAL SOLUTION https://www.empr.com/drug/briviact-oral-solution/ Wed, 01 Sep 2021 18:50:45 +0000 https://www.empr.com/drug/briviact-oral-solution/ Carbamazepine Dosing https://www.empr.com/calculators/carbamazepine-dosing/ Thu, 04 Feb 2016 02:25:05 +0000 https://www.empr.com/uncategorized/carbamazepine-dosing/ Start Over

Start Over

]]>
CARBATROL https://www.empr.com/drug/carbatrol/ Mon, 01 May 2023 19:51:38 +0000 https://www.empr.com/drug/carbatrol/ CELONTIN https://www.empr.com/drug/celontin/ Thu, 22 Jul 2021 11:30:04 +0000 https://www.empr.com/drug/celontin/ CEREBYX https://www.empr.com/drug/cerebyx/ Thu, 22 Jul 2021 11:15:02 +0000 https://www.empr.com/drug/cerebyx/ Clonazepam Orally-Disintegrating Tabs https://www.empr.com/drug/clonazepam-orally-disintegrating-tabs/ Fri, 17 Feb 2023 17:37:25 +0000 https://www.empr.com/drug/clonazepam-orally-disintegrating-tabs/ Corrected Phenytoin (Albumin) https://www.empr.com/calculators/corrected-phenytoin-albumin/ Wed, 03 Feb 2016 20:42:27 +0000 https://www.empr.com/uncategorized/corrected-phenytoin-albumin/ Start Over

Start Over

]]>
DEPAKOTE https://www.empr.com/drug/depakote/ Mon, 13 Mar 2023 18:33:43 +0000 https://www.empr.com/drug/depakote/ DEPAKOTE ER https://www.empr.com/drug/depakote-er/ Mon, 13 Mar 2023 18:34:50 +0000 https://www.empr.com/drug/depakote-er/ DEPAKOTE ERDivalproex sodium 250mg, 500mg; ext-rel tabs.]]> DEPAKOTE ER]]> DEPAKOTE SPRINKLE https://www.empr.com/drug/depakote-sprinkle/ Mon, 13 Mar 2023 18:34:25 +0000 https://www.empr.com/drug/depakote-sprinkle/ DEPAKOTE SPRINKLEDivalproex sodium 125mg; coated particles in caps.]]> DEPAKOTE SPRINKLE]]> DIACOMIT https://www.empr.com/drug/diacomit/ Tue, 16 Aug 2022 13:21:53 +0000 https://www.empr.com/drug/diacomit/ DIACOMIT ORAL SUSP https://www.empr.com/drug/diacomit-oral-susp/ Tue, 16 Aug 2022 13:22:35 +0000 https://www.empr.com/drug/diacomit-oral-susp/ DIASTAT https://www.empr.com/drug/diastat/ Thu, 23 Feb 2023 20:33:42 +0000 https://www.empr.com/drug/diastat/ Diazepam Injection https://www.empr.com/drug/diazepam-injection/ Fri, 17 Feb 2023 19:51:34 +0000 https://www.empr.com/drug/diazepam-injection/ Diazepam Intensol https://www.empr.com/drug/diazepam-intensol/ Thu, 23 Feb 2023 20:18:23 +0000 https://www.empr.com/drug/diazepam-intensol/ Diazepam Oral Solution https://www.empr.com/drug/diazepam-oral-solution/ Thu, 23 Feb 2023 20:18:06 +0000 https://www.empr.com/drug/diazepam-oral-solution/